Overexpression of Cullin7 is associated with hepatocellular carcinoma progression and pathogenesis

[1]  Z. Gong,et al.  Males develop faster and more severe hepatocellular carcinoma than females in krasV12 transgenic zebrafish , 2017, Scientific Reports.

[2]  F. Sonohara,et al.  Prognostic significance of AKR1B10 gene expression in hepatocellular carcinoma and surrounding non-tumorous liver tissue. , 2016, Oncology letters.

[3]  Qing-an Jia,et al.  Decreased Expression of TMEM173 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma , 2016, PloS one.

[4]  Yong Gao,et al.  G3BP1 contributes to tumor metastasis via upregulation of Slug expression in hepatocellular carcinoma. , 2016, American journal of cancer research.

[5]  M. Fujino,et al.  Early Prediction of the Outcome Using Tumor Markers and mRECIST in Unresectable Hepatocellular Carcinoma Patients Who Underwent Transarterial Chemoembolization , 2016, Oncology.

[6]  Lei Shi,et al.  KLHL21, a novel gene that contributes to the progression of hepatocellular carcinoma , 2016, BMC Cancer.

[7]  J. Bian,et al.  Combretastatin A-1 phosphate, a microtubule inhibitor, acts on both hepatocellular carcinoma cells and tumor-associated macrophages by inhibiting the Wnt/β-catenin pathway. , 2016, Cancer letters.

[8]  Xi Chen,et al.  Systematic tracking of disrupted modules identifies significant genes and pathways in hepatocellular carcinoma , 2016, Oncology letters.

[9]  F. Greten,et al.  High levels of the soluble programmed death-ligand (sPD-L1) identify hepatocellular carcinoma patients with a poor prognosis. , 2016, European journal of cancer.

[10]  Guo-Zhong Ji,et al.  BCAT1 expression in hepatocellular carcinoma. , 2016, Clinics and research in hepatology and gastroenterology.

[11]  Donghui Zhang,et al.  Inhibition of Liver Carcinoma Cell Invasion and Metastasis by Knockdown of Cullin7 In Vitro and In Vivo , 2016, Oncology research.

[12]  Jie Xi,et al.  High Expression of Cullin7 Correlates with Unfavorable Prognosis in Epithelial Ovarian Cancer Patients , 2016, Cancer investigation.

[13]  K. Sung,et al.  Treatment of hepatocellular carcinoma with portal venous tumor thrombosis: A comprehensive review. , 2016, World journal of gastroenterology.

[14]  Abhijeet Waghray,et al.  Hepatocellular carcinoma: From diagnosis to treatment. , 2015, World journal of hepatology.

[15]  X. Men,et al.  Cullin7 Is Required for Lung Cancer Cell Proliferation and Is Overexpressed in Lung Cancer , 2015, Oncology research.

[16]  Yan Wang,et al.  Overexpressed ubiquitin ligase Cullin7 in breast cancer promotes cell proliferation and invasion via down-regulating p53. , 2014, Biochemical and biophysical research communications.

[17]  Ying Sun,et al.  Estrogen promotes stemness and invasiveness of ER-positive breast cancer cells through Gli1 activation , 2014, Molecular Cancer.

[18]  G. Gores,et al.  Hepatocellular carcinoma: clinical frontiers and perspectives , 2014, Gut.

[19]  Yunshan Wang,et al.  CUL4A is overexpressed in human pituitary adenomas and regulates pituitary tumor cell proliferation , 2014, Journal of Neuro-Oncology.

[20]  Yunshan Wang,et al.  Involvement of CUL4A in Regulation of Multidrug Resistance to P-gp Substrate Drugs in Breast Cancer Cells , 2013, Molecules.

[21]  J. Soulier,et al.  Cullin7: a new gene involved in liver carcinogenesis related to metabolic syndrome , 2012, Gut.

[22]  T. Shimada,et al.  Oral administration of Enterococcus faecalis FK-23 suppresses Th17 cell development and attenuates allergic airway responses in mice. , 2012, International journal of molecular medicine.

[23]  Cheng Zhu,et al.  Ubiquitin Ligase Cullin 7 Induces Epithelial-Mesenchymal Transition in Human Choriocarcinoma Cells* , 2010, The Journal of Biological Chemistry.

[24]  Z. Pan,et al.  The Cullin7 E3 ubiquitin ligase: A novel player in growth control , 2008, Cell cycle.

[25]  T. Hagen,et al.  Characterization of the Cullin7 E3 ubiquitin ligase--heterodimerization of cullin substrate receptors as a novel mechanism to regulate cullin E3 ligase activity. , 2012, Cellular signalling.